CENTRIC HEALTH (TSE:CHH) Upgraded to Buy at Echelon Wealth Partners

Echelon Wealth Partners upgraded shares of CENTRIC HEALTH (TSE:CHH) from a hold rating to a buy rating in a report released on Tuesday morning, Zacks.com reports.

TSE CHH traded down C$811,505.85 during trading on Tuesday, hitting C$0.15. 806,600 shares of the company’s stock traded hands, compared to its average volume of 155,708. The stock has a market capitalization of $33.31 million and a price-to-earnings ratio of -1.95. CENTRIC HEALTH has a 12-month low of C$0.10 and a 12-month high of C$0.35. The business has a 50 day moving average of C$0.14 and a 200-day moving average of C$0.15.

CENTRIC HEALTH Company Profile

Centric Health Corporation provides healthcare services to patients and customers in Canada. It operates through two segments, Specialty Pharmacy, and Surgical and Medical Centres. The Specialty Pharmacy segment provides traditional pharmacy services, such as compounding and dispensing medications, as well as clinical and specialty services for long term care and retirement communities.

See Also: What is a put option?

Receive News & Ratings for CENTRIC HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CENTRIC HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.